Revised. Amendments from Version 1
==================================

In this version, we have expanded the discussion to address the reviewers\' concerns around definitions of preterm birth and stillbirth used as well as to add global context to our estimates of the frequencies of adverse birth outcomes. We have updated Figure 2 to illustrate the co-occurrence of very preterm birth, very small-for-gestational-age, and stillbirth. We present an additional linear regression analysis of continuous exposures and continuous outcomes and note that maternal height is not associated with either preterm birth or small-for-gestational-age.

Introduction
============

The often overlapping outcomes of preterm birth (PTB), small for gestational age (SGA), and stillbirth (SB), collectively called 'adverse birth outcomes', are responsible for most perinatal morbidity and mortality worldwide. ^[@ref-1],\ [@ref-2]^ Low- and middle-income countries bear the overwhelming burden of global PTB, SB, and SGA. ^[@ref-3]--\ [@ref-5]^ However, reliable classification and estimation of adverse birth outcomes in low-resources settings is challenging because of a number of interrelated factors, including (1) uncertain gestational age dating, ^[@ref-6]^ (2) conflation of fetal growth restriction and PTB into the less useful metric of 'low birthweight', ^[@ref-3],\ [@ref-5]^ (3) inconsistent thresholds for fetal viability, ^[@ref-7]^ and (4) misclassification of stillbirth and neonatal death. ^[@ref-8],\ [@ref-9]^ In many countries, including Zambia, data sources that adequately address these methodological challenges are lacking to the extent that national estimates of adverse birth outcomes must be modeled. ^[@ref-3],\ [@ref-6],\ [@ref-10],\ [@ref-11]^

In sub-Saharan Africa, cohort studies in pregnancy rarely use reliable gestational age dating or clinical phenotyping to classify outcomes. Deliberate clinical phenotyping that characterizes the events that incite parturition (i.e., spontaneous vs. provider-initiated), quantifies maternal and fetal co-morbid conditions, and reliably distinguishes the timing of perinatal death is essential for rigorous classification of adverse birth outcomes. ^[@ref-12],\ [@ref-13]^ Accurate estimation of gestational age with fetal ultrasound is also critical. Other dating methods, such as maternal recall of last menstrual period (LMP), ^[@ref-14]--\ [@ref-17]^ symphisial-fundal height measurement, ^[@ref-18]^ or newborn physical exam ^[@ref-19],\ [@ref-20]^ introduce error (and in some cases, bias ^[@ref-21]^).

We established a cohort of 1450 pregnant women and their infants at a tertiary care institution in Lusaka, Zambia, with the goal of better understanding the epidemiological factors and biological mechanisms leading to adverse birth outcomes. This report presents the outcomes of the first phase of this cohort.

Methods
=======

The Zambian Preterm Birth Prevention Study (ZAPPS) is an ongoing prospective observational cohort study at the Women and Newborn Hospital of the University Teaching Hospitals (UTH-WNH), the primary referral hospital in Lusaka. Phase 1 of ZAPPS, the subject of this report, recruited and enrolled participants beginning in August 2015 and completed follow-up in June 2018. The sample size for this observational study was initially set at 2000 women, with a target of 250 preterm birth events based on published regional population estimates. ^[@ref-4]^ For budgetary reasons and because the prematurity rate was higher than initially expected, enrollment was stopped in September 2017 after 1450 women had been enrolled. The ZAPPS protocol was developed to align with the Guidelines for Strengthening The Reporting of Observational Studies in Epidemiology (STROBE). ^[@ref-22]^

Study population
----------------

Pregnant women meeting the following criteria were eligible for enrollment in Phase 1 of the ZAPPS cohort: (1) 18 years of age or older; (2) viable intrauterine singleton or twin gestation; (3) presentation to antenatal care prior to 20 weeks of gestation if HIV-uninfected or 24 weeks if HIV-infected; (4) residing within Lusaka with no plans to relocate during the study follow-up period; (4) willing to provide written, informed consent; (5) willing to allow participation of their infant(s) in the study; (6) willing to be contacted and followed up at home if necessary.

The ZAPPS protocol was approved prior to study initiation and is subjected to annual review by the University of Zambia School of Medicine Biomedical Research Ethics Committee (reference number: 016-04-14) and the University of North Carolina School of Medicine Institutional Review Board (study number: 14-2113). The study also received approval from the Zambian Ministry of Health National Health Research Authority. Each participant provided written informed consent before enrollment.

Procedures
----------

Full study procedures are described in detail elsewhere. ^[@ref-23]^ Community educators identified potential participants at antenatal care clinics of UTH-WNH and five surrounding clinics in Lusaka, assessing basic eligibility criteria such as age and approximate gestational age. Interested volunteers underwent ultrasound examination per standard of care to determine pregnancy location, fetal viability, number of fetuses, and gestational age by standard biometry (Sonosite M-Turbo, Fuji Sonosite, Bothell, WA). Gestational age was calculated at enrollment by crown-rump length if \<14 gestational weeks or by head circumference and femur length if ≥14 weeks. Fetal biometry structures were each measured twice and then averaged to calculate gestational age using INTERGROWTH-21st equations. ^[@ref-24],\ [@ref-25]^ Pregnancies below the lower threshold for INTERGROWTH-21st equations were dated by the Hadlock formula. ^[@ref-26]^ Interested women who met preliminary ultrasound eligibility criteria completed an informed consent process in their preferred language of English, Nyanja, or Bemba.

At enrollment, study nurses collected demographic and behavioral information through medical record review and participant interview, and documented a thorough health history including prior pregnancy outcomes. As part of standard antenatal care, participants underwent a physical exam and rapid testing for hemoglobin, urinalysis, syphilis (SD Bioline Syphilis 3.0, Abbott Diagnostics), and HIV (SD Bioline 3.0, Abbott Diagnostics).

After enrollment, participants received routine antenatal care at follow-up visits scheduled at approximately 24 weeks, 32 weeks, and 36 weeks. All participants underwent cervical length measurement in the second trimester (i.e., 14--28 weeks) and fetal growth assessment by biometry in the third trimester. ^[@ref-27],\ [@ref-28]^ Cervical length measurements were performed by sonographers with certification in the [Cervical Length Education and Review (CLEAR) program](https://clear.perinatalquality.org/). Study nurses staffed the UTH-WNH labor ward full-time and collected detailed information about the clinical course and perinatal outcomes of participants and their infants, including gestational age at birth, neonatal vital status, birthweight, and sex, and assigned a delivery phenotype. For participants who did not deliver at UTH-WNH or were not captured by study staff during their delivery admission, study staff collected perinatal outcomes either in person or by phone. Cohort retention in this analysis was defined as ascertainment of date of delivery.

Exposures
---------

Primary exposures evaluated included maternal age (years), height (cm), and body mass index (BMI, kg/m ^2^); reported prior preterm birth (nulliparous, parous with no prior PTB, or parous with one or more prior PTB); cervical length (mm) and short cervix (\<25mm); gestation (single or twin); hypertension during pregnancy (≥140 systolic or ≥90mmHg diastolic at any antepartum study visit); anemia at enrollment (\<10.5g/dL); bacteriuria during pregnancy (1+ leukocyte esterase and/or nitrites at any antepartum study visit); syphilis seropositivity (reactive at enrollment); and HIV seropositivity (reactive at enrollment).

Outcomes
--------

Primary outcomes of this analysis were: PTB, defined as birth between 16 ^0^/ ~7~ and 36 ^6^/ ~7~ gestational weeks, SGA (newborn weight-for-age \<10th percentile by INTERGROWTH-21st norms), ^[@ref-29]^ and SB (delivery of an infant without signs of life ≥16 ^0^/ ~7~ weeks). Secondary outcomes included very PTB (birth before 34 ^0^/ ~7~ weeks), very SGA (newborn weight-for-age \<3rd percentile), gestational duration (days), and birthweight centile for gestational age at delivery. Both PTB and very PTB were further characterized as either spontaneous (spontaneous labor or membrane rupture prior to labor) or provider-initiated (induction of labor or pre-labor cesarean). We differentiated antepartum stillbirth (i.e., fetal heart tones absent on admission or, if not assessed, maceration skin changes present at delivery) from intrapartum stillbirth (i.e., fetal heart tones present on admission or, if not assessed, absence of maceration skin changes at delivery).

Statistical analysis
--------------------

We performed descriptive analyses of baseline characteristics and exposures of the cohort, reporting median and interquartile range (IQR) for continuous variables, and frequency and percent for categorical variables. Differences in baseline characteristics between women retained at delivery and those lost to follow-up were evaluated by univariate tests of association.

We summarized parturition phenotype among our retained participants by preterm versus term and spontaneous versus provider-initiated following a standard rubric. ^[@ref-12]^ Among spontaneous PTB, we identified primary maternal, fetal, and/or placental conditions present at the time of delivery. Among provider-initiated PTB, we reported the primary indication for delivery as recorded by the provider. Finally, key individual conditions present and phenotypic clusters were used to classify all PTB, spontaneous PTB, and provider-initiated PTB.

We calculated the incidence of adverse birth outcomes: PTB, spontaneous PTB, very PTB, spontaneous very PTB, SGA, very SGA, and SB among all participants retained at delivery. Twin deliveries in which at least one neonate was SGA or stillborn were classified as having met the respective outcome. Crude associations between key exposures and outcomes were analyzed as risk ratios estimated using Poisson regression analyses with a robust variance. ^[@ref-30]^ Adjusted risk ratios were also estimated using Poisson regression accounting for other key exposures plus maternal age, BMI, estimated gestational age at enrollment, and HIV serostatus at enrollment. We then analyzed the association between continuous exposure variables and outcomes (gestational duration and birthweight centile by gestational age at birth) using linear regression.

Kaplan-Meier curves were plotted for time to delivery for participants with and without a history of prior PTB, short cervix, and twin gestation. We accounted for loss to follow-up by right censoring women at their last study visit (if before delivery) and compared survival between exposure groups by log-rank tests. We also used Cox regression to calculate the hazard of delivery between participants with and without prior PTB, short cervix, and twin gestation, adjusting for maternal age. The proportional-hazards assumption was tested based on Schoenfeld residuals. ^[@ref-31]^ Because of the inherent converging of survival curves in pregnancy at term, we restricted our models to the preterm period by administratively censoring all participants at 37 gestational weeks. ^[@ref-32],\ [@ref-33]^

All statistical analyses were performed with Stata version 14 (College Station, TX, USA) and SAS version 9.4 (Cary, NC, USA).

Results
=======

From August 2015 to September 2017, 1784 pregnant women were screened and 1450 (81%) enrolled ( [Figure 1](#f1){ref-type="fig"}). ^[@ref-23]^ The median age of enrolled participants was 27 (IQR: 23--32) ( [Table 1](#T1){ref-type="table"}). ^[@ref-34]^ Median estimated gestational age (EGA) at enrollment was 16 weeks; 30% (n=427/1450) were enrolled before 14 completed gestational weeks. Of 1042 (72%) participants who had been pregnant at least once in the past; 19% (n=194/1042) reported a prior miscarriage. Of 992 (68%) with a prior delivery, 41% (n=411) reported a prior PTB. On ultrasound exam, 3% (n=35/1175) had short cervix \<25mm, and 3% (n=38/1450) had twin gestation. The prevalence of HIV seropositivity at enrollment was 24% (n=350/1447). Syphilis seropositivity was detected in 5% (70/1342).

![ZAPPS cohort participant flowchart.\
ANC, antenatal care; UTH-WNH, Women and Newborn Hospital of University Teaching Hospital.](gatesopenres-3-14236-g0000){#f1}

###### Baseline characteristics of ZAPPS cohort, N=1450.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Characteristic                                              Total enrolled\   Retained at delivery visit\   Lost to follow-up\   *p*                                           
                                                              N=1450            N=1216 (83.9%)                N=234 (16.1%)                                                      
  ----------------------------------------------------------- ----------------- ----------------------------- -------------------- ------------------- ----- ------------------- --------
  Maternal age, years                                         1409              27 (23--32)                   1192                 27 (23--32)         217   24 (20--29)         \<.001

     \<20                                                     111               7.9                           72                   6.0                 39    18.0                

     20--34                                                   1116              79.2                          956                  80.2                160   73.7                

     ≥35                                                      182               12.9                          164                  13.8                18    8.3                 

     Missing                                                  41                                              24                                       17                        

  Maternal education, years                                   1435              12 (9--12)                    1204                 12 (9--12)          231   9 (7--12)           \<.001

     None                                                     26                1.8                           19                   1.6                 7     3.0                 

     0--12 years                                              1225              85.4                          1018                 84.6                207   89.6                

     ≥12 years                                                184               12.8                          167                  13.9                17    7.4                 

     Missing                                                  15                                              12                                       3                         

  Married or cohabiting                                       1202              83.7                          1014                 84.1                188   81.4                0.310

     Missing                                                  13                                              10                                       3                         

  Electricity in home                                         1302              90.6                          1105                 91.6                197   85.3                0.002

     Missing                                                  13                                              10                                       3                         

  Piped drinking water in home                                1340              93.3                          1123                 93.2                217   93.9                0.678

     Missing                                                  14                                              11                                       3                         

  Toilet facilities in home                                                                                                                                                      \<.001

     Flush or Pour                                            762               53.0                          667                  55.3                95    41.1                

     Pit / Latrine / Other                                    675               47.0                          539                  44.7                136   58.9                

     Missing                                                  13                                              10                                       3                         

  Floor material in home                                                                                                                                                         0.438

     Natural / rudimentary                                    138               9.6                           119                  9.9                 19    8.2                 

     Finished                                                 1299              90.4                          1087                 90.1                212   91.8                

     Missing                                                  13                                              10                                       3                         

  Domestic violence in past year                              71                5.0                           58                   4.9                 13    5.6                 0.641

     Missing                                                  28                                              26                                       2                         

  Smoking in pregnancy                                        8                 0.6                           7                    0.6                 1     0.4                 0.768

     Missing                                                  24                                              23                                       1                         

  Alcohol use in pregnancy                                    124               8.7                           106                  8.9                 18    7.7                 0.563

     Missing                                                  25                                              24                                       1                         

  Maternal height at enrollment, cm                           1368              156 (160--164)                1151                 156 (160--165)      217   156 (160--164)      0.263

  BMI at enrollment, kg/m ^2^                                 1366              23.6 (21.2--27.2)             1149                 23.9 (21.4--27.6)   217   22.7 (20.7--25.5)   \<.001

     \<18.5                                                   71                5.2                           56                   4.9                 15    6.9                 

     18.5--30.0                                               1103              80.8                          919                  80.0                184   84.8                

     \>30.0                                                   192               14.1                          174                  15.1                18    8.3                 

     Missing                                                  84                                              67                                       17                        

  Gravidity                                                   1450              2 (1--4)                      1042                 2 (1--4)            408   2 (1--3)            0.003

     Primigravida                                             408               28.1                          321                  26.4                87    37.2                0.001

     Multigravida                                             1042              71.9                          895                  73.6                147   62.8                

  Prior miscarriage, n=1042                                                                                                                                                      0.933

     Multigravida, no prior miscarriage                       848               81.4                          728                  81.3                120   81.6                

     Multigravida, ≥1 prior miscarriage                       194               18.6                          167                  18.7                27    18.4                

  Parity                                                      1450              1 (0--2)                      1216                 1 (0--2)            234   1 (0--2)            0.004

     Nulliparous                                              458               31.6                          365                  30.0                93    39.7                0.003

     Parous                                                   992               68.4                          851                  70.0                141   60.3                

  Prior PTB, n=992                                                                                                                                                               0.224

     Parous, no prior PTB                                     581               58.6                          505                  59.3                76    53.9                

     Parous, ≥1 prior PTB                                     411               41.4                          346                  40.7                65    46.1                

  Prior stillbirth, n=992                                                                                                                                                        0.401

     Parous, no prior SB                                      780               86.1                          672                  86.5                108   83.7                

     Parous, ≥1 prior SB                                      126               13.9                          105                  13.5                21    16.3                

     Missing                                                  86                                              74                                       12                        

  Short cervix \< 2.5 cm                                      35                3.0                           32                   3.0                 3     3.2                 0.899

     Missing                                                  275                                             135                                      140                       

  Twin gestation                                              38                2.6                           31                   2.6                 7     3.0                 0.698

  HIV positive at enrollment                                  350               24.2                          304                  25.0                46    19.7                0.084

     Missing                                                  3                                               2                                        1                         

  Syphilis reactive                                           70                5.2                           63                   5.6                 7     3.1                 0.142

     Missing                                                  108                                             93                                       15                        

  Hypertensive at enrollment ^[\^](#FN2){ref-type="other"}^   52                3.7                           46                   3.9                 6     2.7                 0.392

     Missing                                                  31                                              21                                       10                        

  Hemoglobin at enrollment, g/dL                              1025              12 (11--13)                   854                  12 (11--13)         171   12 (11--13)         0.274

     \<10.5                                                   140               13.7                          123                  14.4                17    9.9                 

     Missing                                                  425                                             362                                      63                        

  Abnormal UA at enrollment *[†](#FN2){ref-type="other"}*     69                5.0                           55                   4.8                 14    6.3                 0.343

     Missing                                                  79                                              67                                       12                        

  EGA at enrollment, weeks                                    1450              16.1 (13.3--18.3)             1216                 16.0 (13.3--18.3)   234   16.3 (13.3--18.6)   0.421

     \<14                                                     427               29.4                          362                  29.8                65    27.8                
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BMI, body mass index; PTB, preterm birth; SB, stillbirth; UA, urinalysis; EGA, estimated gestational age; IQR, interquartile range.

\* Not all columns sum to 100% due to rounding.

^\^^ Defined as systolic blood pressure ≥ 140 and/or diastolic blood pressure ≥ 90.

*†* Defined as 1+ leukocyte esterase and/or + nitrites.

p values calculated by Wilcoxon rank sum or chi-square for continuous and categorical comparisons, respectively.

Of enrolled participants, 1216 (84%) were retained with delivery date ascertained. Compared to participants lost to follow-up, those retained at delivery were older (median: 27 versus 24 years, p\<.001), had more years of education (median: 12 versus 9 years, p\<.001), were more likely to have electricity (91% versus 85%, p=.002) and flush or pour toilet facilities at home (55% versus 41%, p\<.001), had higher body mass index (23.9 versus 22.7 kg/m ^2^, p\<.001), and had higher gravidity (74% versus 63% multigravid, p=.001) and parity (70% versus 60% parous, p=.004).

Frequencies of our outcomes were as follows: 15% PTB (n=181/1216), 8% very PTB (n=92/1216), 18% SGA (n=207/1159), 7% very SGA (n=80/1159), and 4% SB (n=53/1209). Three participants (0.3%) experienced miscarriages before 16 weeks of gestation. Of the pregnancies that ended in SB, 44 (83%) were antepartum and 9 (17%) occurred intrapartum. Among 1159 deliveries within the EGA range for SGA calculation and with birthweight recorded, ^[@ref-35]^ 150 (13%) were PTB, 65 (6%) were very PTB, 207 (18%) were SGA, 80 (7%) were very SGA, and 32 (3%) were stillborn ( [Figure 2](#f2){ref-type="fig"}).

![Preterm birth, very preterm birth, small for gestational age, very small for gestational age, and stillbirth among participants retained at delivery in ZAPPS cohort.\
Among ZAPPS cohort participants retained at delivery, 15% (181/1216) were preterm (PTB), 8% (92/1216) were very PTB, 18% (207/1159) were small for gestational age (SGA), 7% (80/1159) were very SGA, and 4% (53/1209) were stillborn (SB). \*11 preterm births (\^9 of which were very preterm), one term stillbirth, and 20 preterm stillbirths (\^18 of which were very preterm) were either outside the gestational age threshold for INTERGROWTH-21 ^st^ calculation of SGA, ^[@ref-28]^ or were missing birthweight at delivery. Figures created with: EulerAPE. ^[@ref-36]^](gatesopenres-3-14236-g0001){#f2}

Of 181 total PTB, 120 (66%) occurred spontaneously, 56 (31%) were provider-initiated, and 5 (3%) could not be definitively classified ( [Figure 3](#f3){ref-type="fig"}). The most common key conditions present in women with spontaneous PTB (n=120) were HIV infection (n=42, 35%), SB (n=26, 23%), hypertension alone (n=22; 18%), and twin gestation (n=18, 15%); 33 (28%) had no key condition identified. Most provider-initiated preterm deliveries were indicated for SB (n=16, 29%), preeclampsia or eclampsia (n=15, 27%) or hypertension alone (n=4, 7%), or both SB and preeclampsia (n=4, 7%). We identified major phenotypic clusters of PTB, spontaneous PTB, and provider-initiated PTB by presence of maternal, fetal, and/or placental conditions ( [Table 2](#T2){ref-type="table"}).

![Parturition phenotypes among ZAPPS participants with preterm delivery.\
Of participants who underwent preterm delivery (n=181) in the ZAPPS cohort, 120 of them were spontaneous and 56 were indicated. This figure presents the frequencies of primary conditions present in spontaneous preterm deliveries, primary indications for indicated preterm deliveries, and the overall frequency with 95% confidence intervals of key conditions in each group. Gray bars represent missing values. APH, antepartum hemorrhage; OB HX, obstetrical history.](gatesopenres-3-14236-g0002){#f3}

###### Phenotypes of preterm birth in ZAPPS cohort, N=181.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                 All preterm birth\                   Spontaneous\                        Provider-initiated\                            
                                                 N (%) [\*](#FN4){ref-type="other"}   N (%) [†](#FN5){ref-type="other"}   N (%) [†](#FN5){ref-type="other"}              
  ---------------------------------------------- ------------------------------------ ----------------------------------- ----------------------------------- ----- ---- -----
  **All preterm**                                181                                  100                                 120                                 68    56   32

  **Phenotypic clusters**                                                                                                                                                

     No significant clinical conditions          41                                   23                                  33                                  87    5    13

     Maternal condition(s) only                  60                                   33                                  40                                  67    20   33

     Fetal condition(s) only                     27                                   15                                  21                                  81    5    19

     Placental condition(s) only                 4                                    2                                   1                                   25    3    75

     Maternal and fetal conditions               37                                   20                                  17                                  47    19   53

     Maternal and placental conditions           6                                    3                                   3                                   50    3    50

     Fetal and placental conditions              1                                    1                                   1                                   100   0    0

     Maternal, fetal, and placental conditions   5                                    3                                   4                                   80    1    20

  **Significant maternal conditions**            108                                  60                                  64                                  60    43   40

     HIV infection                               53                                   29                                  42                                  81    10   19

     Urinary tract infection, n=41               9                                    22                                  7                                   78    2    22

     Clinical chorioamnionitis, n=120            1                                    1                                   1                                   100   0    0

     Diabetes (mellitus or gestational), n=179   5                                    3                                   1                                   20    4    80

     Hypertension                                34                                   19                                  19                                  56    15   44

     Preeclampsia, n=107                         23                                   21                                  6                                   26    17   74

     Eclampsia, n=125                            5                                    4                                   0                                   0     5    100

  **Significant fetal conditions**               70                                   39                                  43                                  63    25   37

     Twin gestation                              21                                   12                                  18                                  90    2    10

     Stillbirth, n=176                           48                                   27                                  26                                  55    21   45

     Fetal growth restriction                    2                                    1                                   0                                   0     2    100

     Fetal distress                              1                                    1                                   0                                   0     1    100

     Polyhydramnios                              1                                    1                                   0                                   0     1    100

     Oligohydramnios                             1                                    1                                   0                                   0     1    100

  **Significant placental conditions**           16                                   9                                   9                                   56    7    44

     Placental abruption                         15                                   8                                   9                                   60    6    40

     Placenta previa                             4                                    2                                   0                                   0     4    100
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* column percent.

† row percent.

Maternal age ≥35, prior PTB, short cervix, twin gestation, antenatal hypertension, and EGA at enrollment \<14 weeks were associated with PTB ( [Table 3](#T3){ref-type="table"}). Overall, these associations were stable or strengthened when restricting the outcome to spontaneous PTB and to very PTB ( [Table 4](#T4){ref-type="table"}). Although associated with PTB, antenatal hypertension did not significantly predict spontaneous phenotypes of PTB. Maternal height was not significantly associated with PTB or very PTB in univariate analyses. In multivariable regression models adjusting for maternal age, BMI, EGA at enrollment, and HIV status at enrollment, participants with prior PTB (aRR 1.88; 95% CI 1.32--2.68), short cervix (aRR 2.62; 95% CI 1.68--4.09), twin gestation (aRR 5.22; 95% CI 3.67--7.43), and antenatal hypertension (aRR 2.04; 95% CI 1.43--2.91) had increased risk of PTB ( [Table 2](#T2){ref-type="table"}). The associations between the exposures of prior PTB, short cervix, and twin gestation with PTB were stable or strengthened when restricting the outcome to spontaneous phenotypes and very PTB ( [Table 4](#T4){ref-type="table"}). The risk of PTB decreased with increasing cervical length (RR 0.58 per cm; 95% CI 0.46--0.73) ( [Figure 4](#f4){ref-type="fig"}). In multiple linear regression of continuous exposure variables, gestational duration was associated with number of prior PTB (coeff -5.11 days; 95% CI -6.42 to -3.79), cervical length (coeff 6.49 days; 95% CI 4.18--8.81), and EGA at enrollment (0.70 days; 0.28--1.12) ( [Table 6](#T6){ref-type="table"}).

###### Risk of adverse birth outcomes among ZAPPS participants retained at delivery, n=1213.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Exposure                                      Preterm birth 16 to \<37 weeks   Spontaneous preterm birth 16 to \<37 weeks   Small for gestational age   Stillbirth                                                                                                                                                                                                           
  --------------------------------------------- -------------------------------- -------------------------------------------- --------------------------- ------------ --------- ------ --------- ------ ------ --------- ------ --------- ------ --------- --------- ------ --------- ------ --------- --------- --------- --------- ------ --------- ------ --------- ------ ---------
  Age at enrollment, years                                                                                                                                                                                                                                                                                                                                                     

     \<20                                       72                               5                                            6.9                         1.00                   70     3         4.3    1.00             70     13        18.6   1.00                72     0         0.0    \-                                                                               

     20--34                                     953                              144                                          15.1                        2.18         0.92--\   950    103       10.8   2.53   0.82--\   911    157       17.2   0.93      0.56--\   954    39        4.1    1.00                                                                             
                                                                                                                                                                       5.14                                     7.77                                        1.55                                                                                                               

     ≥35                                        164                              31                                           18.9                        2.72         1.10--\   164    13        7.9    1.85   0.54--\   155    33        21.3   1.15      0.64--\   159    14        8.8    2.15      1.20--\                                                                
                                                                                                                                                                       6.72                                     6.29                                        2.04                                        3.88                                                                   

  BMI at enrollment, kg/m ^2^                                                                                                                                                                                                                                                                                                                                                  

     \<18.5                                     56                               12                                           21.4                        1.00                   56     10        17.9   1.00             53     10        18.9   1.00                55     1         1.8    1.00                                                                             

     18.5--30.0                                 916                              136                                          14.9                        0.69         0.41--\   912    90        9.9    0.55   0.30--\   876    172       19.6   1.04      0.59--\   913    41        4.5    2.47      0.35--\                                                                
                                                                                                                                                                       1.17                                     1.00                                        1.85                                        17.6                                                                   

     \>30.0                                     174                              20                                           11.5                        0.54         0.28--\   173    10        5.8    0.32   0.14--\   168    18        10.7   0.57      0.28--\   173    7         4.1    2.23      0.28--\                                                                
                                                                                                                                                                       1.03                                     0.74                                        1.15                                        17.7                                                                   

  Prior PTB                                                                                                                                                                                                                                                                                                                                                                    

     Nulliparous                                364                              40                                           11.0                        1.13         0.76--\   0.93   0.60--\   363    25     6.9       1.23   0.73--\   0.86   0.47--\   345       73     21.2      1.42   1.06--\   1.36      0.98--\   363       8      2.2       0.62   0.27--\   0.95   0.36--\
                                                                                                                                                                       1.68             1.43                                     2.08             1.55                                        1.91                1.87                                        1.40             2.50

     Parous, no prior\                          504                              49                                           9.7                         1.00         1.00      502    28        5.6    1.00   1.00      491    73        14.9   1.00      1.00      503    18        3.6    1.00      1.00                                                                   
  PTB                                                                                                                                                                                                                                                                                                                                                                          

     Parous, ≥1 prior\                          345                              92                                           26.7                        2.74         1.99--\   1.88   1.32--\   343    67     19.5      3.5    2.30--\   2.62   1.69--\   323       61     18.9      1.27   0.93--\   1.12      0.82--\   343       27     7.9       2.20   1.23--\   1.63   0.78--\
  PTB                                                                                                                                                                  3.77             2.68                                     5.33             4.06                                        1.73                1.54                                        3.93             3.40

  Cervical length                                                                                                                                                                                                                                                                                                                                                              

     ≥2.5cm                                     1049                             137                                          13.1                        1.00         1.00      1045   91        8.7    1.00   1.00      1021   181       17.7   1.00                1046   35        3.4    1.00      1.00                                                                   

     \<2.5cm                                    32                               16                                           50.0                        3.83         2.62--\   2.62   1.68--\   32     9      28.1      3.23   1.79--\   1.95   1.01--\   31        9      29.0      1.64   0.93--\   32        6         18.8      5.60   2.54--\   6.42   2.56--\          
                                                                                                                                                                       5.60             4.09                                     5.81             3.77                                        2.89                                           12.4             16.1             

  Gestation                                                                                                                                                                                                                                                                                                                                                                    

     Single                                     1182                             160                                          13.5                        1.00         1.00      1178   102       8.7    1.00   1.00      1128   191       16.9   1.00      1.00      1177   51        4.3    1.00                                                                             

     Twin                                       31                               21                                           67.7                        5.00         3.77--\   5.22   3.67--\   30     18     60.0      6.93   4.90--\   7.86   5.37--\   31        16     51.6      3.05   2.12--\   2.75      1.81--\   31        2      6.5       1.49   0.38--\          
                                                                                                                                                                       6.64             7.43                                     9.80             11.5                                        4.39                4.18                                        5.85             

  HIV serostatus at\                                                                                                                                                                                                                                                                                                                                                           
  enrollment                                                                                                                                                                                                                                                                                                                                                                   

     Negative                                   908                              128                                          14.1                        1.00         1.00      904    78        8.6    1.00   1.00      871    152       17.5   1.00      1.00      906    37        4.1    1.00      1.00                                                                   

     Positive                                   303                              53                                           17.5                        1.24         0.93--\   1.17   0.85--\   302    42     13.9      1.61   1.13--\   1.36   0.91--\   286       55     19.2      1.10   0.83--\   1.09      0.80--\   301       16     5.3       1.30   0.73--\   1.29   0.65--\
                                                                                                                                                                       1.66             1.62                                     2.29             2.03                                        1.46                1.47                                        2.31             2.56

  Syphilis                                                                                                                                                                                                                                                                                                                                                                     

     Non-reactive                               1057                             159                                          15.0                        1.00                   1053   109       10.4   1.00             1006   184       18.3   1.00                1053   41        3.9    1.00      1.00                                                                   

     Reactive                                   63                               9                                            14.3                        0.95         0.51--\   63     3         4.8    0.46   0.15--\   63     13        20.6   1.13      0.68--\   63     6         9.5    2.45      1.08--\   2.34      0.91--\                                            
                                                                                                                                                                       1.77                                     1.41                                        1.86                                        5.55                6.04                                               

  Blood pressure\                                                                                                                                                                                                                                                                                                                                                              
  during pregnancy                                                                                                                                                                                                                                                                                                                                                             

     Normotensive                               1072                             145                                          13.5                        1.00         1.00      1067   106       9.9    1.00             1025   173       16.9   1.00      1.00      1068   42        3.9    1.00      1.00                                                                   

     Hypertensive [‡](#FN7){ref-type="other"}   141                              36                                           25.5                        1.89         1.37--\   2.04   1.43--\   141    14     9.9       1.00   0.59--\   134    34        25.4      1.50   1.09--\   1.62   1.16--\   141       11        7.8       1.98   1.05--\   1.83   0.84--\          
                                                                                                                                                                       2.60             2.91                                     1.70                                        2.07             2.26                                           3.76             3.96             

  Hemoglobin at\                                                                                                                                                                                                                                                                                                                                                               
  enrollment                                                                                                                                                                                                                                                                                                                                                                   

     ≥10.5 g/dL                                 730                              111                                          15.2                        1.00                   727    70        9.6    1.00             700    125       17.9   1.00                726    30        4.1    1.19      0.51--\                                                                
                                                                                                                                                                                                                                                                                                        2.80                                                                   

     \<10.5 g/dL                                121                              21                                           17.4                        1.14         0.75--\   121    15        12.4   1.29   0.76--\   113    20        17.7   0.99      0.65--\   122    6         4.9    1.00                                                                             
                                                                                                                                                                       1.75                                     2.17                                        1.52                                                                                                               

  UA during\                                                                                                                                                                                                                                                                                                                                                                   
  pregnancy                                                                                                                                                                                                                                                                                                                                                                    

     Normal                                     907                              125                                          13.8                        1.00                   903    82        9.1    1.00             880    168       19.1   1.00                903    32        3.5    1.00                                                                             

     Abnormal ^[\^](#FN8){ref-type="other"}^    189                              31                                           16.4                        1.19         0.83--\   189    20        10.6   1.17   0.73--\   182    26        14.3   0.75      0.51--\   191    6         3.1    0.89      0.38--\                                                                
                                                                                                                                                                       1.71                                     1.85                                        1.10                                        2.09                                                                   

  EGA at\                                                                                                                                                                                                                                                                                                                                                                      
  enrollment, weeks                                                                                                                                                                                                                                                                                                                                                            

     \<14                                       360                              72                                           20.0                        1.00                   358    45        12.6   1.00             333    62        18.6   1.00                357    20        5.6    1.00                                                                             

     ≥14                                        853                              109                                          12.8                        0.64         0.49--\   850    75        8.8    0.70   0.50--\   826    145       17.6   0.94      0.72--\   851    33        3.9    0.69      0.40--\                                                                
                                                                                                                                                                       0.84                                     0.99                                        1.23                                        1.19                                                                   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BMI, body mass index; PTB, preterm birth; UA, urinalysis; EGA, estimated gestational age; RR, relative risk; CI, confidence interval; aRR, adjusted risk ratio

\* Risk ratios calculated via Poisson regression with robust error variance. Multivariable model estimates of adjusted risk ratios include other exposure variables listed and all models adjusted for: maternal age, maternal BMI, and EGA at enrollment as continuous variables.

‡ Defined as systolic blood pressure ≥ 140 and/or diastolic blood pressure ≥ 90 at enrollment or at any follow-up ANC visit.

^\^^ Defined as 1+ leukocyte esterase and/or + nitrites.

###### Risk of severe adverse birth outcomes in ZAPPS participants retained at delivery, n=1213.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Exposure                                       Very preterm birth 16 to \<34 weeks   Spontaneous very preterm birth 16 to \<34 weeks   Very small for gestational age                                                                                                                                                                         
  ---------------------------------------------- ------------------------------------- ------------------------------------------------- -------------------------------- ------ ------------ ------ ------------ ----- ------ ------------ ------ ------------ ------ ------------ ------------ ------ ------------ ------ ------------ ------ ------------
  Age at enrollment,\                                                                                                                                                                                                                                                                                                                           
  years                                                                                                                                                                                                                                                                                                                                         

     \<20                                        72                                    3                                                 4.2                              1.00                71     2            2.8   1.00                70     7            10.0   1.00                                                                     

     20--34                                      953                                   75                                                7.9                              1.89   0.61--5.84   950    50           5.3   1.87   0.46--7.53   913    55           6.0    1.66         0.79--3.51                                                  

     ≥35                                         164                                   13                                                7.9                              1.90   0.56--6.48   164    6            3.7   1.30   0.27--6.28   155    17           11.0   1.82         1.09--3.05                                                  

  BMI at enrollment,\                                                                                                                                                                                                                                                                                                                           
  kg/m ^2^                                                                                                                                                                                                                                                                                                                                      

     \<18.5                                      56                                    4                                                 7.1                              1.00                56     3            5.4   1.00                53     8            15.1   1.00                                                                     

     18.5--30.0                                  916                                   72                                                7.9                              1.10   0.42--2.90   913    46           5.0   0.94   0.30--2.93   879    60           6.8    0.45         0.23--0.90                                                  

     \>30.0                                      174                                   9                                                 5.2                              0.72   0.23--2.27   173    5            2.9   0.54   0.13--2.19   167    10           6.0    0.40         0.17--0.95                                                  

  Prior PTB                                                                                                                                                                                                                                                                                                                                     

     Nulliparous                                 364                                   22                                                6.0                              1.45   0.81--2.60   1.10   0.55--2.21   364   14     3.9          1.61   0.75--3.44   0.88   0.34--2.31   345          32     9.3          1.98   1.18--3.32   1.92   1.12--3.32

     Parous, no prior\                           504                                   21                                                4.2                              1.00   1.00         502    12           2.4   1.00   1.00         491    23           4.7    1.00         1.00                                                        
  PTB                                                                                                                                                                                                                                                                                                                                           

     Parous, ≥1 prior\                           345                                   49                                                14.2                             3.41   2.08--5.58   2.27   1.28--4.04   343   33     9.6          4.02   2.11--7.68   2.89   1.39--5.98   323          25     7.7          1.65   0.95--2.86   1.39   0.76--2.53
  PTB                                                                                                                                                                                                                                                                                                                                           

  Cervical length                                                                                                                                                                                                                                                                                                                               

     ≥2.5cm                                      1049                                  63                                                6.0                              1.00   1.00         1046   39           3.7   1.00   1.00         1022   68           6.7    1.00         1.00                                                        

     \<2.5cm                                     32                                    12                                                37.5                             6.24   3.76--10.4   3.97   2.15--7.33   32    7      21.9         5.87   2.84--12.1   3.19   1.35--7.55   31           5      16.1         2.42   1.05--5.59   2.06   0.88--4.82

  Gestation                                                                                                                                                                                                                                                                                                                                     

     Single                                      1182                                  81                                                6.9                              1.00   1.00         1179   51           4.3   1.00   1.00         1130   74           6.6    1.00         1.00                                                        

     Twin                                        31                                    11                                                35.5                             5.18   3.08--8.70   5.18   2.75--9.77   30    8      26.7         6.16   3.21--11.8   7.53   3.58--15.9   31           6      19.4         2.96   1.39--6.27   2.71   1.12--6.57

  HIV serostatus at\                                                                                                                                                                                                                                                                                                                            
  enrollment                                                                                                                                                                                                                                                                                                                                    

     Negative                                    908                                   67                                                7.4                              1.00   1.00         905    41           4.5   1.00   1.00         871    61           7.0    1.00         1.00                                                        

     Positive                                    303                                   25                                                8.3                              1.12   0.72--1.74   1.20   0.71--2.01   302   18     6.0          1.32   0.77--2.26   1.35   0.68--2.66   286          19     6.6          0.95   0.58--1.56   0.86   0.48--1.53

  Syphilis                                                                                                                                                                                                                                                                                                                                      

     Non-reactive                                1057                                  81                                                7.7                              1.00                1054   53           5.0   1.00                1009   71           7.0    1.00                                                                     

     Reactive                                    63                                    5                                                 7.9                              1.04   0.44--2.46   63     2            3.2   0.63   0.16--2.53   63     6            9.5    1.35         0.61--2.99                                                  

  Blood pressure\                                                                                                                                                                                                                                                                                                                               
  during pregnancy                                                                                                                                                                                                                                                                                                                              

     Normotensive                                1072                                  78                                                7.3                              1.00                1068   55           5.2   1.00                1025   65           6.3    1.00         1.00                                                        

     Hypertensive [‡](#FN10){ref-type="other"}   141                                   14                                                9.9                              1.36   0.79--2.34   141    4            2.8   0.55   0.20--1.50   134    15           11.2   1.77         1.04--3.00   1.68   0.92--3.06                              

  Hemoglobin at\                                                                                                                                                                                                                                                                                                                                
  enrollment                                                                                                                                                                                                                                                                                                                                    

     ≥10.5 g/dL                                  730                                   60                                                8.2                              1.00                727    35           4.8   1.00                703    46           6.5    1.00                                                                     

     \<10.5 g/dL                                 121                                   7                                                 5.8                              0.70   0.33--1.50   121    5            4.1   0.86   0.34--2.15   113    5            4.4    0.68         0.27--1.67                                                  

  UA during\                                                                                                                                                                                                                                                                                                                                    
  pregnancy                                                                                                                                                                                                                                                                                                                                     

     Normal                                      907                                   59                                                6.5                              1.00                904    37           4.1   1.00                881    68           7.7    1.00                                                                     

     Abnormal ^[\^](#FN11){ref-type="other"}^    189                                   14                                                7.4                              1.14   0.65--2.00   189    7            3.7   0.81   0.41--2.00   183    10           5.5    0.71         0.37--1.35                                                  

  EGA at\                                                                                                                                                                                                                                                                                                                                       
  enrollment, weeks                                                                                                                                                                                                                                                                                                                             

     \<14                                        360                                   39                                                10.8                             1.00                358    26           7.3   1.00                333    25           7.5    1.00                                                                     

     ≥14                                         853                                   53                                                6.2                              0.57   0.39--0.85   851    33           3.9   0.92   0.86--0.99   828    55           6.6    0.88         0.56--1.40                                                  
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BMI, body mass index; PTB, preterm birth; UA, urinalysis; EGA, estimated gestational age; RR, relative risk; CI, confidence interval; aRR, adjusted risk ratio

\* Risk ratios calculated via Poisson regression with robust error variance. Multivariable models include other exposure variables listed and adjusted for: maternal age, maternal BMI, and EGA at enrollment.

‡ Defined as systolic blood pressure ≥ 140 and/or diastolic blood pressure ≥ 90 at enrollment or at any follow-up visit.

^\^^ Defined as 1+ leukocyte esterase and/or + nitrites.

![Predicted probability of preterm birth \<37 weeks by mid-trimester cervical length.\
Among ZAPPS cohort participants with a cervical length measured by ultrasound in the second trimester (n=1081), the probability of preterm birth \<37 weeks decreased with increasing cervical length. PTB, preterm birth; RR, relative risk; CI, confidence interval.](gatesopenres-3-14236-g0003){#f4}

Nulliparity, twin gestation, and antenatal hypertension were each associated with SGA in univariate analysis, and older age, low BMI, nulliparity, short cervix, twin gestation, and antenatal hypertension were associated with very SGA. In multivariable analysis, twin gestation (aRR 2.75; 95% CI 1.81--4.18) and antenatal hypertension (aRR 1.62; 95% CI 1.16--2.26) were associated with an increased risk of SGA; nulliparity was marginally associated with SGA (aRR 1.36; 95% CI 0.98--1.87). Nulliparity (aRR 1.92; 95% CI 1.12--3.32) and twin gestation (aRR 2.71, 95% CI 1.12--6.57) were associated with very SGA. Maternal height was not associated with SGA or very SGA in univariate analyses of categorical outcomes, but was associated with mean centile of birthweight in adjusted linear regression (coeff 0.32; 95% CI 0.04,0.59), along with maternal weight (coeff 0.34; 95% CI 0.21,0.47), and EGA at enrollment (coeff -0.75; 95% CI -1.25 to -0.25) ( [Table 6](#T6){ref-type="table"}).

Finally, older maternal age, prior PTB, short cervix, syphilis seropositivity, and antenatal hypertension were individually associated with an elevated risk of SB ( [Table 3](#T3){ref-type="table"}). In multivariable analysis, short cervix predicted SB (aRR 6.42; 95% CI 2.56--16.1), while syphilis was only marginally associated (aRR 2.34; 95% CI 0.91--6.04).

Elevated risks of PTB among women with prior PTB, short cervix, and twin gestation were supported by survival analyses, with log-rank tests of association demonstrating significant differences between groups of each variable ( [Figure 5](#f5){ref-type="fig"}; [Table 5](#T5){ref-type="table"}). In proportional hazards models adjusted for maternal age at enrollment, participants with prior PTB, short cervix, and twin gestation had significantly higher hazards of delivering before 37 gestational weeks compared to parous women with no prior PTB, women with cervical lengths ≥25mm, or with single gestations. Participants with increasing numbers of prior preterm births demonstrated increasing hazard ratios of delivering preterm.

![Kaplan-Meier survival curves by ( **a**) prior preterm birth, ( **b**) short cervix (\<25mm), and ( **c**) twin gestation. Survival curves are presented for participants with increasing numbers of prior preterm birth, those with cervical length \<25mm compared to ≥25 mm, and those with twin compared to singleton gestation. The dashed vertical line represents a gestational age of 37 weeks, the threshold for preterm versus term delivery. EGA, estimated gestational age; PTB, preterm birth.](gatesopenres-3-14236-g0004){#f5}

###### Log-rank and Cox proportional hazards regression with test of proportionality assumption for prior preterm birth, short cervical length, and twin gestation.

  --------------------------------------------------------------------------------------------------------------------------------
                        Log-rank                                 Cox proportional\   Schoenfeld\                            
                                                                 hazards             residual test                          
  --------------------- ---------------------------------------- ------------------- --------------- ------- ------- ------ ------
  Prior preterm birth                                            *global*            3.23            0.66                   

     Parous, no prior   \<.001 ^[\^](#FN13){ref-type="other"}^   *ref*               *ref*                                  

     Parous, 1 prior    2.21                                     1.47-- 3.33         \<.001          -0.01   0.01    0.92   

     Parous, 2 prior    2.79                                     1.70-- 4.58         \<.001          0.00    0.00    0.95   

     Parous, 3+ prior   4.70                                     2.94-- 7.53         \<.001          -0.11   2.33    0.13   

     Nulliparous        \-                                       1.16                0.75-- 1.78     0.51    -0.06   0.80   0.37

  Cervical length                                                *global*            4.42            0.11                   

     ≥ 25mm             \<.001                                   *ref*               *ref*                                  

     \<25mm             5.19                                     3.09-- 8.74         \<.001          -0.15   3.26    0.07   

  Gestation                                                      *global*            3.19            0.20                   

     Singleton          \<.001                                   *ref*               *ref*                                  

     Twin               6.70                                     4.25-- 10.60        \<.001          0.13    3.19    0.07   
  --------------------------------------------------------------------------------------------------------------------------------

HR, hazards ratio; CI, confidence interval.

\* Each proportional hazards model adjusted for maternal age at enrollment.

^\^^ log-rank of trend, excluding nulliparas.

###### Association between continuous exposures by gestational duration and birthweight centile.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Exposure                            Gestational duration, days   Birthweight centile for gestational age                                                       
  ----------------------------------- ---------------------------- ----------------------------------------- ------- ------------- ------- ------------- ------- -------------
  Age at enrollment, years            -0.18                        -0.44,0.08                                                      0.30    0.01,0.60     -0.02   -0.32,0.29

  Maternal height at enrollment, m    -0.05                        -0.28,0.17                                                      0.63    0.37,0.88     0.32    0.04,0.59

  Maternal weight at enrollment, kg   -0.01                        -0.11,0.09                                                      0.41    0.30,0.53     0.34    0.21,0.47

  BMI at enrollment, kg/m ^2^         0.09                         -0.20,0.37                                                      0.84    0.51,1.17             

  Number of prior PTB                 -6.54                        -8.07,-5.00                               -5.11   -6.42,-3.79   -1.94   -3.80,-0.07           

  Cervical length                     6.93                         5.05,8.82                                 6.49    4.18,8.81     0.87    -1.84,3.58            

  Systolic blood pressure at\         -0.11                        -0.22,0.01                                                      -0.05   -0.18,0.08            
  enrollment                                                                                                                                                     

  Diastolic blood pressure at\        -0.17                        -0.32,-0.02                                                     -0.01   -0.18,0.17            
  enrollment                                                                                                                                                     

  Hemoglobin at enrollment            0.45                         -0.59,1.48                                                      1.17    -0.01,2.34            

  EGA at enrollment, weeks            1.12                         0.70,1.54                                 0.70    0.28,1.12     -0.77   -1.26,-0.29   -0.75   -1.25,-0.25
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Coefficients and confidence intervals calculated by linear regression. Adjusted coefficients calculated in multivariable models that included other exposure variables with estimates shown.

PTB, preterm birth; EGA, estimated gestational age; coeff, coefficient; CI, confidence interval.

Discussion
==========

We present the primary results of the ZAPPS pregnancy cohort, established to evaluate the risk factors associated with adverse birth outcomes in Lusaka, Zambia. This study was notable for enrollment of pregnant women at early presentation to antenatal care, gestational age determination by early ultrasound, universal cervical length screening, comprehensive and uniform antenatal and postpartum care, and clinical phenotyping of birth outcomes. Our analyses revealed strong risks of prior preterm birth, short mid-trimester cervical length, and twin gestation on incident preterm birth, and these risks were supported by analyses of pregnancy 'survival' to term. We also report increased risks of small-for-gestational-age infants among nulliparous women and women with twin gestation, and of stillbirth among those with short cervix.

The proportion of gravidas who deliver before term varies significantly across individual studies and national estimates in sub-Saharan Africa. The most recent global report estimated a PTB rate of 8% in Europe and 11% in North America, compared to 12% across sub-Saharan Africa and 12% in Zambia specifically, where the rate was based on modeled regional estimates instead of national data. ^[@ref-6]^ In contrast, a census accounting of 237,219 public sector births over 6 years in Lusaka --- where the vast majority of pregnancies are dated by last menstrual period --- classified 46% of singleton deliveries as preterm. ^[@ref-37],\ [@ref-38]^ In Zambia, obstetrical ultrasound is rare and the reliance on maternal recall of LMP alone substantially over-estimates preterm birth rates, ^[@ref-17],\ [@ref-39]^ an inaccuracy that worsens with later presentation to care. ^[@ref-21]^ We report PTB based on ultrasound gestational age dating and prospectively ascertained delivery outcomes such that our data are likely more accurate than reports that rely on LMP recall or regional models.

Inconsistent global PTB definitions hinder inter-regional comparisons of rates and risk factors, and we acknowledge that gestational age boundaries are somewhat arbitrary. We chose a lower gestational age limit of 16 weeks because of evidence of similar etiological risk factors between preterm births occurring as early as 16 weeks and those that occur later in pregnancy ^[@ref-12],\ [@ref-40]^. In addition, we included preterm stillbirths in our definition of PTB since excluding stillbirths that occur in the process of parturition would falsely lower the rate of PTB. In a sensitivity analysis that excluded all stillbirths from PTB outcomes, the PTB incidence was modestly reduced. However, risk estimates calculated in regression models remained stable, which supports evidence that risk factors for live and stillborn PTB demonstrate substantial overlap ^[@ref-40]^.

The distinction of preterm parturition as spontaneously occurring versus provider-initiated is important but rarely reported from national surveillance or clinical research data in low-resource settings. Deliveries that are preceded by spontaneous labor or membrane rupture are phenotypically distinct from those that are induced medically or surgically for complications such as preeclampsia, antepartum fetal demise, or other maternal or fetal conditions. ^[@ref-12],\ [@ref-41]--\ [@ref-44]^ Further classification based on primary conditions present in spontaneous PTB and the primary indications for provider-initiated PTB is based on a standardized rubric proposed to elucidate phenotypic clusters of PTB ^[@ref-12]^. An understanding of prevailing phenotypes can direct research, policy, and preventive interventions towards regional and population-specific needs. ^[@ref-13],\ [@ref-45],\ [@ref-46]^ While our cohort is limited by a small number of PTB events (n=181), we were able to classify nearly all (i.e., 97%) as either spontaneous or provider-initiated, and to identify the primary complications and phenotypic characteristics of each. Further granularity and generalizability of PTB classification requires a larger sample size, signaling a need for future high-quality obstetrical research on a greater scale.

As with PTB classification, identifying infants born SGA requires accurate gestational age estimation, which can be at best imprecise, and at worst biased, when based solely on LMP. ^[@ref-21]^ The incidence of SGA in our cohort (18%) was modestly higher than regional estimates of SGA in sub-Saharan Africa of 16%, ^[@ref-5]^ and compared to a recent estimate in Zambia of 13%, which was modeled from published rates in other neighboring countries because of scarcity of data from Zambia itself. ^[@ref-5]^ In comparison to the ZAPPS cohort, in which older maternal age, low BMI, nulliparity, twin gestation, and antenatal hypertension predicted either SGA or very SGA, a study among over 19,000 singletons in Tanzania identified *younger* maternal age, height, and nulliparity as strong risk factors for SGA. ^[@ref-47]^ The WHO Multi-country Survey on Maternal and Newborn Health found nulliparity and hypertensive disorders to indicate higher risk of preterm SGA and hypertensive disorders, sociodemographic factors, and anemia to predict term SGA. ^[@ref-48]^ With a much smaller sample size and fewer outcomes compared to these two studies, we were not able to differentiate our outcome by preterm vs. term SGA due to low statistical precision for stratified associations with key risk factors. Due to this low precision, we are not able to discern whether or not SGA outcomes were modified by gestational age at delivery. However, both of these studies relied on reported LMP to estimate gestational age at delivery, which itself may have introduced error. Whether growth restriction is a distinct pathological process before 37 weeks compared to after 37 weeks is unclear. Finally, while the INTERGROWTH-21 ^st^ Project ^[@ref-49]^ intended to define universal fetal growth and newborn weight standards derived from an extensive multi-ethnic sample of women with adequate antenatal care and nutrition, its widespread use over ethnicity-specific or customized standards has been disputed. ^[@ref-43],\ [@ref-50]--\ [@ref-56]^ Despite this, we chose to define SGA in our cohort based on INTERGROWTH-21 ^st^ standards since local standards that include all pregnancies affected by undernutrition and/or pregnancy comorbidities tend to identify only the severest 10% of cases by definition.

Stillbirth, a composite outcome comprising antepartum and intrapartum fetal death, is particularly understudied in low-resource settings. Compared to developed regions with a stillbirth rate of 3.4 per 1000 total births, the rate in sub-Saharan Africa is estimated as 28.7 per 1000, while 4% of our cohort delivered stillbirths. ^[@ref-3]^ The true global burden of stillbirth and its underlying causes are poorly classified due to inconsistent fetal viability limits and imperfect classification of neonatal death versus stillbirth, limited resources for case investigations, under-reporting of home births that result in perinatal death, and inadequate national and regional reporting of identified cases. ^[@ref-3]^ Indeed, recent global and regional estimates of stillbirth included just 17% of its datapoints from sub-Saharan Africa and south Asia, regions that bear 77% of the global burden. ^[@ref-3]^ Data from the recent Zambia Demographic and Health Survey reported a rate of stillbirth, defined as fetal death over 7 months' gestation, as 1.3% among 13,563 births reported, with equal rates outside Lusaka province as within. ^[@ref-57]^ This is similar to estimates from a Global Network study in Zambia, in which 2% of women enrolled delivered stillbirths. ^[@ref-9]^ The higher proportion of deliveries that resulted in stillbirth in the ZAPPS cohort, at least partly attributable to a broader gestational age range, was reflected in the ZEPRS database, in which 6% of 66,395 deliveries at UTH resulted in stillbirth. ^[@ref-38]^ However, over half of stillbirths in ZEPRS and 67% in a Global Network study in Zambia were classified as intrapartum, compared to less than 20% in the ZAPPS cohort. These disparities may result from differential classification; it is standard practice outside of our study to classify stillbirths solely by neonatal skin maceration at delivery, particularly in the absence of but even despite the presence of documented fetal heart activity during labor. ^[@ref-9]^ Indeed, previous studies have demonstrated that reliance on observed skin maceration alone can over-estimate stillbirth proportions attributable to the intrapartum period. ^[@ref-58]^

This study has several limitations, many of which have been noted previously. ^[@ref-23]^ First, 16% of participants were lost to follow-up. While this is commensurate with other longitudinal pregnancy cohort studies in the region, ^[@ref-59],\ [@ref-60]^ error may be introduced if outcomes are not missing at random. ^[@ref-61]^ Women lost to follow-up were younger, more likely to be primigravida and nulliparous, had lower BMIs, and had multiple lower measures of socioeconomic status; many of these characteristics were risk factors for at least one adverse outcome. Further, 250 (21%) of the retained participants either did not deliver at the study hospital or delivered at a time when ZAPPS staff were not present, requiring delivery outcomes to be ascertained by record review and/or participant report (it is worth noting that we found no difference in frequencies of outcomes between deliveries attended by ZAPPS staff versus those that were not; see *Underlying data*). Second, our data have noted missingness of key antenatal test results at baseline (i.e., hemoglobin, syphilis, and urinalysis) because tests were not routinely repeated nor results recorded in our database if performed at the recruitment clinic before enrollment. Of these test results, only syphilis was associated with an outcome (stillbirth), but we cannot determine with certainty whether missingness introduced bias or simply reduced statistical power. Third, while the ZAPPS study recruits from several surrounding primary clinics, it is based at a tertiary referral hospital and many of our participants were drawn from this higher-risk pool. We note high prevalence of prior PTB, miscarriage, and stillbirth, and high HIV and syphilis seropositivity, which may have resulted from self-selection of high-risk women into a cohort study investigating adverse birth outcomes. It is likely that this resulted in an over-representation of outcomes, but less likely to have also introduced a biased association with identified risk factors.

In summary, the ZAPPS cohort study demonstrates high prevalence of antenatal comorbidities and identifies a number of factors associated with increased risks of preterm birth, small-for-gestational-age infants, and stillbirth. This is the first study of its kind to be conducted in Zambia, and one of the largest on the African continent. An understanding of the true global scope of adverse birth outcomes will require consistent definitions, meticulous ascertainment, and systematic reporting that has eluded those settings where the burden of these outcomes is highest. In the absence of sophisticated registry infrastructure, large pregnancy cohort studies may be able to approximate regional incidence estimates and can provide important data to stratify and direct care for pregnancies at highest risk. Future sub-studies using data and stored biological specimens from the ZAPPS cohort will aim to identify underlying biological mechanisms, causal pathways, and appropriate interventions for the accurate prediction and prevention of adverse birth outcomes in Zambia and worldwide.

Data availability
=================

Underlying data
---------------

Open Science Framework: Zambian Preterm Birth Prevention Study (ZAPPS) -- Outcomes. [https://doi.org/10.17605/OSF.IO/WT6Q8](https://dx.doi.org/10.17605/OSF.IO/WT6Q8) ^[@ref-34]^

This project contains the following underlying data:

1.  Z1A minimum dataset 2019-06-30.csv (underlying data for all participants)

2.  Z1A Codebook 2019-06-30.rtf (codebook for the variables within the dataset)

Data are available under the terms of the [Creative Commons Attribution 4.0 International license](https://creativecommons.org/licenses/by/4.0/legalcode) (CC-BY 4.0).

The authors acknowledge the invaluable contributions to the study design and conduct by Eve Lackritz, James Litch, Marcela Castillo, Nancy Hancock, and Nurain Fuseini. The study protocol is registered at ClinicalTrials.gov, identifier: [NCT02738892](https://clinicaltrials.gov/ct2/show/NCT02738892?term=NCT02738892&rank=1).
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In this manuscript, the authors report the rates of adverse birth outcomes such as preterm birth, stillbirth and small for gestational age from a well-characterized cohort of 1450 pregnant women from Zambia. This is a very important article, providing robust data from a low-middle income country like Zambia in the domain of maternal and child health. 

The emphasis on accuracy and precision of gestational age estimation which is a cornerstone in preterm birth research is praise-worthy. The data is well represented and the statistical analyses are appropriate.

***Comments:*** Preterm birth has been defined as birth between 16 0/7 and 36 6/7 gestational weeks in this study. The definition seems to include stillbirths (the proportion of stillbirth among PTB is reported in paragraph 4 of the results section), which is in variance with the convention of reporting preterm birth among live-born babies. What is the rationale behind this choice? Does such a change in definition influence the preterm birth rate in this study population? If so, how much? The lower limit of gestational age for defining preterm birth is taken as 16 0/7 weeks in this study. What was the rationale behind considering 16 weeks as the lower cut-off of preterm birth? Further, one of the inclusion criteria is  *"presentation to antenatal care prior to 20 weeks of gestation if HIV-uninfected or 24 weeks if HIV-infected".* Nearly 50% of the women first present to antenatal care after 16 weeks in this population and 25% above 18.3w (median EGA at enrolment is 16.1 (IQR: 13.3--18.3)w). This means there would be some pregnant women in the population who delivered preterm (between 16 & 24w) who couldn't be a part of the cohort because of the delay in seeking antenatal care. Would that create a bias? If so, how much would this influence the study's estimate of the preterm birth rate in the population? Reporting preterm birth rate among the participants enrolled less than 16 weeks of gestation will add further information in this aspect.   

The manuscript can be accepted for indexing after the resolution of the comments made above.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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We chose to include preterm stillbirths in our definition of preterm birth and demonstrate the overlapping adverse outcomes of preterm birth, stillbirth, and small for gestational age in Figure 2. We acknowledge significant limitations in differentiating intrapartum stillbirth from preterm birth with immediate neonatal death in our setting. We believe that to exclude stillbirths that occur in the process of parturition from spontaneous preterm birth would falsely lower the rate of spontaneous preterm delivery. As we note in the discussion, the categorization of antepartum vs. intrapartum stillbirth is also imperfect. Of 181 preterm deliveries in our cohort, 48 (27%) were stillborn. Excluding stillbirths from our preterm delivery definition reduced preterm delivery from 15% to 11% and spontaneous preterm delivery from 10% to 8%. Despite this overall reduction, excluding stillbirths from our regression models did not significantly alter our estimates of risk, which supports evidence that risk factors for live and stillborn preterm births demonstrate substantial overlap (Kramer 2012). Finally, our cohort was designed to evaluate the risk factors associated with adverse birth outcomes, and not necessarily to estimate population-level rates of these outcomes. We note in the discussion that our study population likely over-represents high-risk women and therefore overestimates the true population incidence of adverse birth outcomes. 

Both lower and upper EGA boundaries for defining preterm birth vary widely in research and national statistics worldwide. Participants at the International Conference on Prematurity and Stillbirth of the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) have argued for including births occurring 16 weeks onward in the definition of preterm birth, citing studies that show similar etiological risk factors for births occurring as early as 16 weeks and those that occur later in the 2 ^nd^ and 3 ^rd^ trimester (Kramer 2012; Villar 2012). We acknowledge that the risk of preterm birth in any cohort increases with earlier gestational age at presentation for precisely the reason explained by the reviewer. There is a strong relationship between EGA at presentation and EGA at delivery, which therefore produces this effect regardless of relatively arbitrary EGA boundaries used to define outcomes. Indeed, the preterm birth rate among participants who enrolled \<16 weeks was 18% in our cohort compared to 12% among those enrolled ≥16 weeks. Because of this, we include EGA at enrollment in all multivariable analyses. We also repeated analyses of preterm delivery outcomes restricting our sample to those participants who presented \<20 weeks and again to those who presented \<16 weeks to evaluate the potential for bias. These restricted analyses had no effect on our results (with the exception of short cervix as an exposure since it was only performed beyond 16 weeks).
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This is an important study and the data presented adds new knowledge about the adverse birth outcomes and their risk factors in low-income countries in sub-Saharan Africa. The advantages of the study include: Well-designed and well-conducted cohort study;Reliable gestational age dating and clinical phenotyping;Well-defined primary exposures and birth outcomes;Distinction between spontaneous and provider-initiated PTB;Comprehensive and reliable data analysis;Results were well-organized clearly presented;Limitations were well noted and discussed. Minor comments: The reviewer recognized that the authors tried to avoid using p-values in this report according to recent guidelines and recommendations. However, sometimes it could be helpful to the readers to comprehend the "substantiality" of the statistical evidence. The reviewer therefore would suggest including p-values in Figure 3, Table 2, etc. (as Table 1).EGA at enrollment (\<14) was shown to be associated with PTB. The authors might compare the baseline characteristics between the samples enrolled before and after 14wks to identify the possible reasons underlying this association (similar to the comparisons made in Table 1). In addition, as the gestational age was calculated differently in the samples enrolled before and after 14wks, the authors might also compare outcomes (e.g. gestation duration) between these two groups to examine whether the two methods could potentially cause systematical difference in the estimation of gestational age.The authors presented the co-occurrence among PTB, SGA and SB using a Venn diagram (Figure 2). It is also interesting to learn whether the frequencies of the co-occurrence of these outcomes were higher than expected especially between the very PTB and very SGA group.The authors dichotomized continuous exposures (e.g. maternal age, BMI) as well as the outcomes (e.g. PTB, SGA) in the association analysis (Table 3). It would be more informative if the authors could also show the results based on association tests of continuous variables.Maternal height has been shown to be associated with gestational duration and birth weight (gestational age adjusted) in previous studies mainly in high-income countries. It is not known whether maternal height is associated with gestational duration (and PTB) in this study or not.In the discussion section, the authors should compare the risk factors (e.g. their occurrence, frequencies and estimated effect sizes) and the frequencies of adverse birth outcomes reported in this study with those reported in high-income countries.
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The authors thank the reviewer for the thoughtful and constructive comments. Please find a point-by-point response to each comment here.  *We have elected not to include*p *values in our tables beyond Table 1 because the we think point estimates and their 95% confidence intervals are the best estimates of association. (see Harrington et al NEJM 2019 https://www.nejm.org/doi/full/10.1056/NEJMe1906559).  Thank you for this suggestion. In response to the other reviewer's comment regarding the increased risk of PTB with EGA at enrollment, we have repeated analyses of preterm delivery outcomes restricting our sample to those participants who presented \<20 weeks and again those who presented \<16 weeks to evaluate the potential for bias and our results proved stable. We also include EGA at enrollment in all multivariable analyses. We think that additional reporting of which baseline characteristics differ by EGA at enrollment and investigation of the effect of ultrasound algorithms used for EGA calculation is beyond the scope (and page limit) of this analysis but may be explored in future analyses. Thank you for this suggestion. We have added a second Euler diagram to Figure 2 to illustrate the co-occurrence of very PTB, very SGA, and stillbirth.We have added linear regression of continuous exposures and continuous outcomes (Table 6). We have noted in the results section that maternal height was not associated with either PTB or SGA. It was similarly not associated with gestational duration.We have added additional global context to our estimates of the frequencies of adverse birth outcomes in the discussion section. However, we acknowledge significant limitations to direct comparisons of risk estimates due to inconsistent definitions. Furthermore, as there is still no undisputed global standard by which to identify small for gestational age neonates, we have not directly compared the incidence of SGA in our cohort to estimates from high-income countries.*
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